FINWIRES · TerminalLIVE
FINWIRES

Japan Shares Rise on BOJ Rate Hike Expectations

By

Japanese shares ended higher on Wednesday after the OECD projected the Bank of Japan's (BOJ) policy rate could rise to 2% by the end of 2027, reinforcing expectations of a sustained monetary-tightening cycle.

The Nikkei 225 rose 0.8%, or 529.54 points, to close at 63,272.11.

The OECD said the Japanese central bank's policy rate remains near the low end of the economy's neutral range and urged gradual rate hikes as inflation stays around 2% and demand continues to outpace supply.

OECD Secretary-General Mathias Cormann said the pace of policy normalization could accelerate as Japan's economic equilibrium becomes clearer, though he said the BOJ was not yet "behind the curve."

The OECD projected the BOJ's policy rate could reach 2% by end-2027 as the central bank continues unwinding monetary easing toward a neutral rate estimated at 1.1% to 2.5%.

In economic news, Japan's current account surplus widened 29.1% year over year to 4.682 trillion yen in March, driven by higher primary income and a wider goods surplus.

Japan's bank lending growth accelerated to 5.4% year over year in April, led by solid loan expansion at major banks and continued strength at regional lenders.

On the corporate front, Bandai Namco (TYO:7832) rose 5% after reporting stronger fiscal 2026 profit and sales growth, driven by robust demand for its Gundam franchise and Toys and Hobby business.

Tsugami (TYO:6101) climbed 7% after its China segment profit jumped 39% year over year on stronger revenue growth. Meanwhile, GNI Group (TYO:2160) advanced 9% after its liver fibrosis drug F351 was accepted for regulatory review in China with priority review status.

Related Articles

Asia

Singapore Exchange Reports 6% Rise in Securities Market Turnover in April

Singapore Exchange (SGX:S68) reported a 6% year-over-year rise in securities market turnover to SG$43.2 billion in April, according to an after-market filing with the Singapore Exchange on Wednesday.Securities daily average value, or SDAV, also jumped 6% year over year to SG$2.1 billion, while derivatives traded volume edged up 1% on year to 30.2 million contracts, with derivatives daily average volume increasing slightly to about 1.5 million contracts.The steady trading volumes were driven by strong participation in small and mid-cap stocks, with SDAV of those stocks rising 8% month over month.Meanwhile, assets under management across exchange-traded funds or ETFs, crossed SG$20 billion in April, representing a 45% year-over-year surge.

$SGX:S68
Asia

Henlius Biotech Gets Nod for Tumor Drug Trial in Australia

Shanghai Henlius Biotech (HKG:2696) obtained approval for a phase 1 clinical trial of HLX48 for injection from Australia's relevant regulatory authorities, according to a Wednesday Hong Kong bourse filing.The drug will be tested for the treatment of advanced/metastatic solid tumors.

$HKG:2696
Asia

Kabra Extrusiontechnik Appoints Interim CFO

Kabra Extrusiontechnik (NSE:KABRAEXTRU, BOM:524109) has appointed Uttam Singh, currently the deputy general manager-accounts and finance, as the interim chief financial officer, according to a Wednesday filing to the Indian stock exchanges.His appointment is effective from Wednesday till a new CFO is appointed by the board.

$BOM:524109$NSE:KABRAEXTRU